Patent ID: 9289435
Filing Date: 2016-03-22
CPC Classification: A61K,A61P

Claim Text:
1. A method of treating leukemia in a subject, comprising administering to the subject a composition comprising a therapeutically effective amount of an agonist for a prostaglandin D receptor, the agonist for a prostaglandin D receptor selected from the group consisting of Δ 12 -prostaglandin J 3 (Δ 12 -PGJ 3 ); 9α,15S-dihydroxy-11-oxo-prosta-5Z,13E-dien-1-oic acid, methyl ester (PGD 2 ME); [[4-[5R-chloro-2Z-[3R-cyclohexyl-3S-hydroxy-1R-propenyl]-3S-hydroxycyclopentyl]-2R-butenyl]oxy]-acetic acid, isopropyl ester (ZK118182); Δ 12 -prostaglandin J 2 (Δ 12 -PGJ 2 ); 15-deoxy-Δ 12,14 -PGJ 2 ; and 16,16-dimethyl-Δ 12 -PGJ 3 .